Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study

被引:3
|
作者
Campman, Sophie L. [1 ,2 ,3 ,17 ]
van Rossem, Gwen [1 ]
Boyd, Anders [1 ,2 ,3 ,4 ]
Coyer, Liza [1 ,2 ,3 ]
Schinkel, Janke [5 ]
Agyemang, Charles [6 ,7 ]
Galenkamp, Henrike [6 ,8 ]
Koopman, Anitra D. M. [6 ,8 ]
Leenstra, Tjalling [1 ]
van der Loeff, Maarten Schim [1 ,2 ,3 ]
van Charante, Eric P. Moll [6 ,8 ,9 ]
van den Born, Bert-Jan H. [8 ,10 ,11 ]
Lok, Anja [12 ,13 ]
Verhoeff, Arnoud [14 ,15 ]
Zwinderman, Aeilko H. [16 ]
Jurriaans, Suzanne
Stronks, Karien [6 ,8 ]
Prins, Maria [1 ,2 ,3 ]
机构
[1] Publ Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands
[2] Amsterdam UMC Locat Univ Amsterdam, Infect Dis, Meibergdreef 9, Amsterdam, Netherlands
[3] Amsterdam Inst Infect & Immun, Infect Dis, Amsterdam, Netherlands
[4] Stichting Hiv Monitoring, Amsterdam, Netherlands
[5] Amsterdam UMC Locat Univ Amsterdam, Med Microbiol & Infect Prevent, Meibergdreef 15, Amsterdam, Netherlands
[6] Amsterdam UMC Locat Univ Amsterdam, Publ & Occupat Hlth, Meibergdreef 9, Amsterdam, Netherlands
[7] Johns Hopkins Univ Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA
[8] Amsterdam Publ Hlth Hlth Behav & Chron Dis, Amsterdam, Netherlands
[9] Amsterdam UMC Locat Univ Amsterdam, Gen Practice, Meibergdreef 9, Amsterdam, Netherlands
[10] Amsterdam UMC Locat Univ Amsterdam, Vasc Med, Meibergdreef 9, Amsterdam, Netherlands
[11] Amsterdam Cardiovasc Sci, Atherosclerosis & Ischem Syndromes, Amsterdam, Netherlands
[12] Amsterdam UMC Locat Univ Amsterdam, Psychiat, Meibergdreef 9, Amsterdam, Netherlands
[13] Amsterdam Publ Hlth, Mental Hlth, Amsterdam, Netherlands
[14] Publ Hlth Serv Amsterdam, Dept Hlth Living, Amsterdam, Netherlands
[15] Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands
[16] Amsterdam UMC Locat Univ Amsterdam, Clin Epidemiol, Biostat & Bioinformat, Meibergdreef 9, Amsterdam, Netherlands
[17] Nieuwe Achtergracht 100, NL-1018 WT Amsterdam, Netherlands
关键词
HELIUS study; SARS-CoV-2; COVID-19; Vaccination; Intent; Ethnicity; HESITANCY; COVID-19;
D O I
10.1016/j.vaccine.2023.02.030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Ethnic minority groups experience a disproportionately high burden of infections, hospitalizations and mortality due to COVID-19, and therefore should be especially encouraged to receive SARSCoV-2 vaccination. This study aimed to investigate the intent to vaccinate against SARS-CoV-2, along with its determinants, in six ethnic groups residing in Amsterdam, the Netherlands.Methods: We analyzed data of participants enrolled in the population-based multi-ethnic HELIUS cohort, aged 24 to 79 years, who were tested for SARS-CoV-2 antibodies and answered questions on vaccination intent from November 23, 2020 to March 31, 2021. During the study period, SARS-CoV-2 vaccination in the Netherlands became available to individuals working in healthcare or > 75 years old. Vaccination intent was measured by two statements on a 7-point Likert scale and categorized into low, medium, and high. Using ordinal logistic regression, we examined the association between ethnicity and lower vaccination intent. We also assessed determinants of lower vaccination intent per ethnic group.Results: A total of 2,068 participants were included (median age 56 years, interquartile range 46-63). High intent to vaccinate was most common in the Dutch ethnic origin group (369/466, 79.2%), followed by the Ghanaian (111/213, 52.1%), South-Asian Surinamese (186/391, 47.6%), Turkish (153/325, 47.1%), African Surinamese (156/362, 43.1%), and Moroccan ethnic groups (92/311, 29.6%). Lower intent to vaccinate was more common in all groups other than the Dutch group (P < 0.001). Being female, believing that COVID-19 is exaggerated in the media, and being < 45 years of age were common determinants of lower SARS-CoV-2 vaccination intent across most ethnic groups. Other identified determinants were specific to certain ethnic groups. Conclusions: Lower intent to vaccinate against SARS-CoV-2 in the largest ethnic minority groups of Amsterdam is a major public health concern. The ethnic-specific and general determinants of lower vac-cination intent observed in this study could help shape vaccination interventions and campaigns.(c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2035 / 2045
页数:11
相关论文
共 50 条
  • [21] Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study
    Ebinger, Joseph E.
    Botwin, Gregory J.
    Albert, Christine M.
    Alotaibi, Mona
    Arditi, Moshe
    Berg, Anders H.
    Binek, Aleksandra
    Botting, Patrick
    Fert-Bober, Justyna
    Figueiredo, Jane C.
    Grein, Jonathan D.
    Hasan, Wohaib
    Henglin, Mir
    Hussain, Shehnaz K.
    Jain, Mohit
    Joung, Sandy
    Karin, Michael
    Kim, Elizabeth H.
    Li, Dalin
    Liu, Yunxian
    Luong, Eric
    McGovern, Dermot P. B.
    Merchant, Akil
    Merin, Noah
    Miles, Peggy B.
    Minissian, Margo
    Nguyen, Trevor Trung
    Raedschelders, Koen
    Rashid, Mohamad A.
    Riera, Celine E.
    Riggs, Richard, V
    Sharma, Sonia
    Sternbach, Sarah
    Sun, Nancy
    Tourtellotte, Warren G.
    Van Eyk, Jennifer E.
    Sobhani, Kimia
    Braun, Jonathan G.
    Cheng, Susan
    BMJ OPEN, 2021, 11 (02):
  • [22] The Effect of Preventive Measures and Vaccination against SARS-CoV-2 on the Infection Risk, Treatment, and Hospitalization: A Cross-Sectional Study of Algeria
    Hamimes, Ahmed
    Aouissi, Hani Amir
    Ababsa, Mostefa
    Lounis, Mohamed
    Jayarajah, Umesh
    Napoli, Christian
    Kasemy, Zaineb A.
    VIRUSES-BASEL, 2022, 14 (12):
  • [23] Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study
    Prakash, Om
    Solanki, Bhavin
    Sheth, Jay K.
    Joshi, Bhavin
    Kadam, Mina
    Vyas, Sheetal
    Shukla, Aparajita
    Tiwari, Hemant
    Rathod, Sanjay
    Rajput, Anil
    Trivedi, Toral
    Ramanuj, Vaibhav
    Solanki, Anand
    BMJ OPEN, 2021, 11 (01):
  • [24] Changes in Endometriosis-Associated Symptoms Following Immunization against SARS-CoV-2: A Cross-Sectional Study
    Lukac, Stefan
    Friedl, Thomas W. P.
    Gruber, Tobias
    Schmid, Marinus
    Leinert, Elena
    Janni, Wolfgang
    Hancke, Katharina
    Dayan, Davut
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [25] THE PREVALENCE AND DETERMINANTS OF SARS-CoV-2 INFECTIONS AMONG HEALTHCARE WORKERS, RESULTS OF A CROSS-SECTIONAL STUDY IN THE SILESIAN VOIVODESHIP
    Wojczyk, Marek
    Kowalska, Malgorzata
    INTERNATIONAL JOURNAL OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH, 2023, 36 (02) : 201 - 213
  • [26] Hesitancy to Undergo SARS-CoV-2 Rapid Antigen Testing in China: Nationwide Cross-sectional Study
    Lu, Zhen
    Fu, Leiwen
    Yang, Luoyao
    Tian, Tian
    Gao, Yanxiao
    Meng, Xiaojun
    Zou, Huachun
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
  • [27] Characteristics of headaches attributed to SARS-CoV-2 vaccination and factors associated with its frequency and prolongation: a cross-sectional cohort study
    Jameie, Melika
    Togha, Mansoureh
    Azizmohammad Looha, Mehdi
    Jafari, Elham
    Yazdan Panah, Mohammad
    Hemmati, Nima
    Nasergivehchi, Somayeh
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [28] Predictors of SARS-CoV-2 Vaccine Uptake among Health Professionals: A Cross-Sectional Study in Ghana
    Mohammed, Abdul-Samed
    Asumah, Mubarick Nungbaso
    Padhi, Bijaya Kumar
    Sinha, Abhinav
    Mohammed, Issah
    Jamil, Safayet
    Boasiako, Osborn Antwi
    Leman, Nladobi
    Kabir, Russell
    VACCINES, 2023, 11 (01)
  • [29] Headaches associated with acute SARS-CoV-2 infection: A prospective cross-sectional study
    Souza, Delon D.
    Shivde, Sonia
    Awatare, Poonam
    Avati, Amrutha
    John, Saji K.
    Badachi, Sagar
    Nadig, Raghunandan
    Sarma, G. R. K.
    Mathew, Thomas
    SAGE OPEN MEDICINE, 2021, 9
  • [30] Executive deficits after SARS-CoV-2 infection: A cross-sectional population study
    Buer, S.
    Hagen, B. I.
    Soraas, A.
    White, R. A.
    Bo, R.
    Ellingjord-Dale, M.
    Istre, M. S.
    Brunvoll, S. H.
    Lerdal, A.
    Landro, N. I.
    Nygaard, A. B.
    Stubberud, J.
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2024, 41